vs

Side-by-side financial comparison of Cardlytics, Inc. (CDLX) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.

Cardlytics, Inc. is the larger business by last-quarter revenue ($50.9M vs $49.0M, roughly 1.0× Quipt Home Medical Corp.). On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -25.5%). Cardlytics, Inc. produced more free cash flow last quarter ($13.0M vs $6.9M).

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.

CDLX vs QIPT — Head-to-Head

Bigger by revenue
CDLX
CDLX
1.0× larger
CDLX
$50.9M
$49.0M
QIPT
Growing faster (revenue YoY)
QIPT
QIPT
+57.7% gap
QIPT
32.3%
-25.5%
CDLX
More free cash flow
CDLX
CDLX
$6.1M more FCF
CDLX
$13.0M
$6.9M
QIPT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDLX
CDLX
QIPT
QIPT
Revenue
$50.9M
$49.0M
Net Profit
$-1.1M
Gross Margin
53.5%
Operating Margin
-12.0%
2.1%
Net Margin
-2.1%
Revenue YoY
-25.5%
32.3%
Net Profit YoY
2.9%
EPS (diluted)
$-0.15
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDLX
CDLX
QIPT
QIPT
Q4 25
$50.9M
$49.0M
Q3 25
$47.0M
$39.8M
Q2 25
$58.0M
$35.1M
Q1 25
$56.4M
$33.3M
Q4 24
$68.3M
$37.1M
Q3 24
$61.1M
Q2 24
$64.0M
Q1 24
$62.2M
Net Profit
CDLX
CDLX
QIPT
QIPT
Q4 25
$-1.1M
Q3 25
$-72.7M
$-3.5M
Q2 25
$-9.3M
$-3.0M
Q1 25
$-13.3M
$-3.0M
Q4 24
$-1.1M
Q3 24
$-145.2M
Q2 24
$-4.3M
Q1 24
$-24.3M
Gross Margin
CDLX
CDLX
QIPT
QIPT
Q4 25
53.5%
Q3 25
48.7%
Q2 25
57.6%
Q1 25
54.6%
Q4 24
52.1%
Q3 24
Q2 24
Q1 24
Operating Margin
CDLX
CDLX
QIPT
QIPT
Q4 25
-12.0%
2.1%
Q3 25
-146.6%
-3.6%
Q2 25
-22.0%
-5.2%
Q1 25
-24.9%
-3.0%
Q4 24
-12.2%
1.2%
Q3 24
-243.1%
Q2 24
-24.7%
Q1 24
-36.7%
Net Margin
CDLX
CDLX
QIPT
QIPT
Q4 25
-2.1%
Q3 25
-154.7%
-8.9%
Q2 25
-16.0%
-8.6%
Q1 25
-23.5%
-9.1%
Q4 24
-2.9%
Q3 24
-237.6%
Q2 24
-6.7%
Q1 24
-39.0%
EPS (diluted)
CDLX
CDLX
QIPT
QIPT
Q4 25
$-0.15
$-0.02
Q3 25
$-1.36
$-0.07
Q2 25
$-0.18
$-0.07
Q1 25
$-0.26
$-0.07
Q4 24
$-0.36
$-0.03
Q3 24
$-2.90
Q2 24
$-0.09
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDLX
CDLX
QIPT
QIPT
Cash + ST InvestmentsLiquidity on hand
$48.7M
$10.5M
Total DebtLower is stronger
$212.6M
$84.0M
Stockholders' EquityBook value
$-6.5M
$113.0M
Total Assets
$285.6M
$280.7M
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDLX
CDLX
QIPT
QIPT
Q4 25
$48.7M
$10.5M
Q3 25
$44.0M
$12.9M
Q2 25
$46.7M
$11.3M
Q1 25
$52.0M
$17.1M
Q4 24
$65.6M
$15.5M
Q3 24
$67.0M
Q2 24
$71.2M
Q1 24
$97.8M
Total Debt
CDLX
CDLX
QIPT
QIPT
Q4 25
$212.6M
$84.0M
Q3 25
$214.6M
$87.6M
Q2 25
$214.3M
$66.0M
Q1 25
$213.9M
$71.5M
Q4 24
$213.6M
$70.6M
Q3 24
$213.2M
Q2 24
$212.9M
Q1 24
$257.9M
Stockholders' Equity
CDLX
CDLX
QIPT
QIPT
Q4 25
$-6.5M
$113.0M
Q3 25
$-4.7M
$112.1M
Q2 25
$58.7M
$102.5M
Q1 25
$64.1M
$103.6M
Q4 24
$70.0M
$106.3M
Q3 24
$69.7M
Q2 24
$210.0M
Q1 24
$199.1M
Total Assets
CDLX
CDLX
QIPT
QIPT
Q4 25
$285.6M
$280.7M
Q3 25
$292.8M
$283.3M
Q2 25
$361.1M
$236.1M
Q1 25
$369.1M
$244.6M
Q4 24
$392.7M
$242.8M
Q3 24
$399.4M
Q2 24
$534.4M
Q1 24
$569.0M
Debt / Equity
CDLX
CDLX
QIPT
QIPT
Q4 25
0.74×
Q3 25
0.78×
Q2 25
3.65×
0.64×
Q1 25
3.34×
0.69×
Q4 24
3.05×
0.66×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDLX
CDLX
QIPT
QIPT
Operating Cash FlowLast quarter
$13.0M
$8.9M
Free Cash FlowOCF − Capex
$13.0M
$6.9M
FCF MarginFCF / Revenue
25.5%
14.0%
Capex IntensityCapex / Revenue
0.0%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M
$26.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDLX
CDLX
QIPT
QIPT
Q4 25
$13.0M
$8.9M
Q3 25
$1.8M
$9.8M
Q2 25
$1.2M
$9.7M
Q1 25
$-6.7M
$8.9M
Q4 24
$3.0M
$9.3M
Q3 24
$1.4M
Q2 24
$4.4M
Q1 24
$-17.6M
Free Cash Flow
CDLX
CDLX
QIPT
QIPT
Q4 25
$13.0M
$6.9M
Q3 25
$1.7M
$8.0M
Q2 25
$903.0K
$4.4M
Q1 25
$-6.8M
$7.3M
Q4 24
$2.9M
$5.6M
Q3 24
$878.0K
Q2 24
$4.1M
Q1 24
$-18.3M
FCF Margin
CDLX
CDLX
QIPT
QIPT
Q4 25
25.5%
14.0%
Q3 25
3.7%
20.0%
Q2 25
1.6%
12.6%
Q1 25
-12.1%
22.0%
Q4 24
4.2%
15.2%
Q3 24
1.4%
Q2 24
6.5%
Q1 24
-29.4%
Capex Intensity
CDLX
CDLX
QIPT
QIPT
Q4 25
0.0%
4.2%
Q3 25
0.0%
4.6%
Q2 25
0.6%
14.9%
Q1 25
0.2%
4.8%
Q4 24
0.2%
9.9%
Q3 24
0.8%
Q2 24
0.4%
Q1 24
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons